A controlled trial reported by Johnson et al. [22] demonstrated that corticosteroid treatment most benefited the seriously ill patient (defined by low serum albumin concentration, low body weight, and severe weight loss) who had extensive tuberculosis. This evidence concerns the gene ALB and tuberculosis.